艾迪注射液联合化疗治疗原发性肝细胞癌系统评价_袁维利.pdf

144 2010 1 25 1 West China edical Journal, Vol. 25, No. 1, January, 2010 1 1 1 2 2* 袁维利 , 乔蓓 , 常静 ,邹林玲 , 张瑞明 ( 11 , 610041;21 GCP , 610041) :: ( Transcatheter arterial chemoembolization TACE) TACE (ÑÒ ) : Cochrane , EDLINECENTRALE BASECB CNKIVIP Cochrane ;; Rev an51 0 eta: eta: Ñ Ò , : , , : ; ; ;; ; [] R7351 7 [ ] A Aidi Injection Plus Transcatheter Arterial Chemoembolization or Chemotherapy forHepatocellular Carcinoma: A System- atic Revie and Meta-Analysis YUAN We-i li, QIAO Bei, CHANG Jing, et al . 11 Dep artmentof Integrated Tradi- tional Chinese and Western Medicine, West China H osp ital, West China School of Med ical, Sichuan Univ ersity , Cheng du 610041, China; 21 Division of Clinical harmocology , West China H osp ital, West China School of Medi- cal, S ichuan University , Chengdu 610041, China Corresp onding author : ZH A NG R ui-ming Abstract: Objective: To compare effectiveness and safety of Aidi injection plus transcatheter arterial chemoembol-i zation ( TACE) or chemotherapy (CT) compared to T ACE or CT alone ( Therapy Ñ versus Therapy Ò ) for hepato- cellular carcinoma ( HCC) by a meta-analysis of all available randomized controlled trials. Methods: We searched the Cochrane Library, EDLINE, CENT RAL, E BASE, CB disc, and CNKI as well as employing manual searches. The quality of included studies was assessed according to the Cochrane library, and meta-analyses were performed by Rev an 51 0 software. Results: Our results showed that Therapy Ñ, compared with Therapy Ò , significantly im- proved the survival, the tumor response, thequality of life, and toxicities such as bonemarrow